Peiminine triggers ferroptosis to inhibit breast cancer growth through triggering Nrf2 signaling DOI

Nian Yi,

Li Wang,

Zhongjun Jiang

и другие.

Tissue and Cell, Год журнала: 2024, Номер 87, С. 102323 - 102323

Опубликована: Фев. 4, 2024

Язык: Английский

Nrf2/Bach1 signaling axis: A promising multifaceted therapeutic strategy for Alzheimer's disease DOI Creative Commons

Priyanka Soni,

Sudarshana M. Sharma, Andrew A. Pieper

и другие.

Neurotherapeutics, Год журнала: 2025, Номер unknown, С. e00586 - e00586

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

1

Reductive stress in cancer: coming out of the shadows DOI
Maolin Ge, Thales Papagiannakopoulos, Liron Bar‐Peled

и другие.

Trends in cancer, Год журнала: 2023, Номер 10(2), С. 103 - 112

Опубликована: Ноя. 2, 2023

Язык: Английский

Процитировано

23

Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression DOI Creative Commons
Janine M. DeBlasi, Aimee Falzone, Samantha Caldwell

и другие.

Cancer Research, Год журнала: 2023, Номер 83(12), С. 1953 - 1967

Опубликована: Апрель 16, 2023

Mutations in the KEAP1-NRF2 (Kelch-like ECH-associated protein 1-nuclear factor-erythroid 2 p45-related factor 2) pathway occur up to a third of non-small cell lung cancer (NSCLC) cases and often confer resistance therapy poor outcomes. Here, we developed murine alleles KEAP1 NRF2 mutations found human NSCLC comprehensively interrogated their impact on tumor initiation progression. Chronic stabilization by Keap1 or Nrf2 mutation was not sufficient induce tumorigenesis, even absence suppressors, p53 LKB1. When combined with KrasG12D/+, constitutive activation promoted early progression hyperplasia low-grade tumors but impaired advanced-grade tumors, which reversed deletion. Finally, overexpression mutant lines detrimental proliferation, viability, anchorage-independent colony formation. Collectively, these results establish context-dependence activity threshold for during tumorigenic process.

Язык: Английский

Процитировано

21

Hypoxia-induced ALDH3A1 promotes the proliferation of non-small-cell lung cancer by regulating energy metabolism reprogramming DOI Creative Commons
Yang Chen,

Hongfei Yan,

Lirong Yan

и другие.

Cell Death and Disease, Год журнала: 2023, Номер 14(9)

Опубликована: Сен. 20, 2023

Abstract Aldehyde dehydrogenase 3A1 (ALDH3A1) is an NAD + -dependent enzyme that closely related to tumor development. However, its role in non-small-cell lung cancer (NSCLC) has not been elucidated. This study aimed clarify the mechanism of ALDH3A1 and identify potential therapeutic targets for NSCLC. Here, first time, we found expression could be induced by a hypoxic environment was highly expressed NSCLC tissue, especially some late-stage patients, associated with poor prognosis. In mechanistic terms, enhances glycolysis suppresses oxidative phosphorylation (OXPHOS) promote cell proliferation activating HIF-1α/LDHA pathway addition, results showed target β-elemene. can downregulated β-elemene inhibit enhance OXPHOS, thus suppressing vitro vivo. conclusion, hypoxia-induced energy metabolic status tumors efficacy β-elemene, providing new theoretical basis better clinical applications

Язык: Английский

Процитировано

20

Peiminine triggers ferroptosis to inhibit breast cancer growth through triggering Nrf2 signaling DOI

Nian Yi,

Li Wang,

Zhongjun Jiang

и другие.

Tissue and Cell, Год журнала: 2024, Номер 87, С. 102323 - 102323

Опубликована: Фев. 4, 2024

Язык: Английский

Процитировано

8